Open Orphan plc (ORPH) First Day of Dealings and Re-admission to AIM and Euronext Growth June 28, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that Admission and dealings in its ordinary shares of 0.1 pence each (“Ordinary Shares”) on AIM and Euronext Growth Dublin will commence at 8.00 a.m. today under the ticker ORPH. Highlights The Company will target the fragmented orphan drug services market in Europe The orphan drug sector is one of the fastest growing sectors in the global pharmaceutical industry and in the US in 2018 over 50%…

Continue reading